P09.2
Abnormal findings on neonatal screening for congenital endocrine disease
Clinical Classification Guidelines
Inclusion Terms
- Abnormal findings on neonatal screening for congenital adrenal hyperplasia
- Abnormal findings on neonatal screening for hypothyroidism screen
Medical Intelligence & Overview
ICD-10 code P09.2 pertains to abnormal findings identified during neonatal screening tests for congenital endocrine diseases. These screenings are vital in detecting certain health conditions early on, including congenital adrenal hyperplasia and hypothyroidism, which can significantly affect a child's development if not diagnosed and treated promptly. While these tests are designed to identify abnormalities, further evaluations are necessary to confirm any diagnosis and determine appropriate next steps.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting hormone production or function Incomplete development of endocrine glands such as the adrenal glands or thyroid gland Inherited metabolic or hormonal disorders Environmental factors that may influence fetal development
Key Symptoms: In newborns, symptoms may be absent or subtle, making screening vital Signs of congenital adrenal hyperplasia may include ambiguous genitalia in genetic females, dehydration, and salt-wasting crisis Symptoms of hypothyroidism in infants can include jaundice, feeding difficulties, poor weight gain, constipation, and lethargy Some affected infants may appear normal initially but can develop health issues if conditions go untreated
Diagnostic & Treatment
Diagnosis Path: The initial detection occurs through newborn screening tests that measure specific hormone levels or metabolites in blood samples collected shortly after birth. If abnormal results are observed, further diagnostic assessments may include:
Treatment Protocols: Treatment options depend on the specific diagnosis confirmed after further testing. Early intervention is crucial for optimal outcomes and generally includes:
Clinical Advice & FAQs
Billing Guidance
Is P09.2 a billable ICD-10 code?
Yes, P09.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P09.2?
Clinical documentation must specify the nature of Abnormal findings on neonatal screening for congenital endocrine disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference